therapies

Immunotherapy and targeted therapies at NSCLC: ESMO 2022 phase 3 data

Breaking abstracts presented at ESMO Congress 2022 highlight the effectiveness of immunotherapies and targeted therapies in non-small cell lung cancer (NSCLC). Long-term survival data from the EMPOWER-Lung 1 phase 3 trial showed that cemiplimab can improve progression-free survival (PFS) and overall survival (OS), compared with chemotherapy, in patients with NSCLC.1 Results from the phase 3 […]

Experts hail combination therapies as future of Alzheimer’s treatment

While promising data from lecanemab from Biogen and Eisai breathed new life into the anti-amyloid approach last week, Alzheimer’s disease is complex enough that combination therapies are likely to play a significant role in future symptomatic treatments. A combination of drugs has proven to be effective in treating various diseases such as cancer and diabetes. […]

Regenerative therapies market size to reach $45,940.7

Regenerative Therapies Market The goal of regenerative medicine is to repair and replace damaged organs and tissues. It has the potential to treat chronic diseases and disorders like Alzheimer’s, diabetes and others.Cell therapy is the therapeutic application of cellular components such as stem cells, autologous cells, xenogenic cells, and others. Cell therapy is used in […]

ACC Recommendations on the Role of Non-Statin Therapies for Lowering LDL-C

An expert consensus statement from the American College of Cardiology (ACC) on the role of non-statin therapies in maintaining low-density lipoprotein cholesterol (LDL-C) levels to manage the risk of atherosclerotic cardiovascular disease (ASCVD) was published in the Journal of the American College of Cardiology. Newer options for non-statin therapy include ezetimibe, alirocumab or evolocumab, bempedoic […]

Sleep Disorder Therapies Market SWOT Analysis By 2028

New Jersey, United States – The Sleep Disorder Therapies Market research report aims to provide a quick overview of the overall industry performance and key new trends. Key insights, as well as findings, the latest key drivers and constraints, are also featured here. Market analysts use a huge range of quantitative and qualitative techniques, including […]

Upstream Bio Launches with $200 Million Series A Financing to Advance New Therapies for Allergic and Inflammatory Diseases

WALTHAM, Mass.–(BUSINESS WIRE)–Upstream Bio, an inflammation-focused biotech company, today debuted a $200 million Series A financing. The funding will enable Upstream to advance the company’s lead program UPB-101, a clinical-stage monoclonal antibody targeting the TSLP receptor, and build a pipeline of assets to target immune-mediated diseases . The Series A round was jointly led by […]

Dupilumab Approved for EoE, Plus Hope for More Therapies

Photo: Getty Images In late May, the U.S. Food and Drug Administration approved dupilumab for eosinophilic esophagitis in patients 12 years and older. This makes it the first approved treatment for EoE, a milestone. dr. Marc Rothenberg, the co-principal investigator of the related clinical trial, called the approval “a victory for science, patients, rare diseases […]

Scroll to top